APA (7th ed.) Citation

A, E., H, H., C, K., J, M., C, R., A, H., . . . C, K. (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828), 1791. https://doi.org/10.1016/s0140-6736(11)61940-5

Chicago Style (17th ed.) Citation

A, Engert, et al. "Reduced-intensity Chemotherapy and PET-guided Radiotherapy in Patients with Advanced Stage Hodgkin's Lymphoma (HD15 Trial): A Randomised, Open-label, Phase 3 Non-inferiority Trial." Lancet 379, no. 9828 (2012): 1791. https://doi.org/10.1016/s0140-6736(11)61940-5.

MLA (9th ed.) Citation

A, Engert, et al. "Reduced-intensity Chemotherapy and PET-guided Radiotherapy in Patients with Advanced Stage Hodgkin's Lymphoma (HD15 Trial): A Randomised, Open-label, Phase 3 Non-inferiority Trial." Lancet, vol. 379, no. 9828, 2012, p. 1791, https://doi.org/10.1016/s0140-6736(11)61940-5.